Video - Angiogenesis inhibitors: Nursing pharmacology
00:00 / 00:00
Video Summary
Angiogenesis inhibitors are a class of drug that inhibits the formation of new blood vessels. They treat cancer as tumors require a blood supply to grow.
Angiogenesis inhibitors work by blocking the receptors on endothelial cells that signal for new blood vessel formation, which prevents the tumor from getting the nutrients it needs to grow. Common examples of angiogenesis inhibitors include Axitinib, Bevacizumab, and Cabozantinib.
For Institutions
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
